Intracellular Th Stock Gross Profit
| ITCI Stock | USD 73.12 0.89 1.20% |
Intracellular Th fundamentals help investors to digest information that contributes to Intracellular's financial success or failures. It also enables traders to predict the movement of Intracellular Stock. The fundamental analysis module provides a way to measure Intracellular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intracellular stock.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 428.4 M | 449.9 M | |
| Gross Profit Margin | 0.93 | 0.97 |
Intracellular | Gross Profit |
Intracellular Th Company Gross Profit Analysis
Intracellular's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Intracellular Gross Profit | 95.16 M |
Most of Intracellular's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intracellular Th is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Intracellular Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for Intracellular is extremely important. It helps to project a fair market value of Intracellular Stock properly, considering its historical fundamentals such as Gross Profit. Since Intracellular's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intracellular's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intracellular's interrelated accounts and indicators.
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Intracellular Th reported 95.16 M of gross profit. This is 95.76% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The gross profit for all United States stocks is 99.65% higher than that of the company.
Intracellular Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intracellular's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intracellular could also be used in its relative valuation, which is a method of valuing Intracellular by comparing valuation metrics of similar companies.Intracellular is currently under evaluation in gross profit category among related companies.
Intracellular Current Valuation Drivers
We derive many important indicators used in calculating different scores of Intracellular from analyzing Intracellular's financial statements. These drivers represent accounts that assess Intracellular's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Intracellular's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 623.1M | 1.9B | 4.3B | 5.0B | 6.9B | 7.2B | |
| Enterprise Value | 568.2M | 1.8B | 4.2B | 4.8B | 6.7B | 7.1B |
Intracellular Fundamentals
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 6.68 B | ||||
| Shares Outstanding | 104.33 M | ||||
| Shares Owned By Insiders | 2.35 % | ||||
| Shares Owned By Institutions | 93.13 % | ||||
| Number Of Shares Shorted | 3.47 M | ||||
| Price To Earning | (6.56) X | ||||
| Price To Book | 10.78 X | ||||
| Price To Sales | 13.73 X | ||||
| Revenue | 462.18 M | ||||
| Gross Profit | 95.16 M | ||||
| EBITDA | (158.85 M) | ||||
| Net Income | (139.67 M) | ||||
| Cash And Equivalents | 628.74 M | ||||
| Cash Per Share | 6.64 X | ||||
| Total Debt | 16.94 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 9.81 X | ||||
| Book Value Per Share | 6.14 X | ||||
| Cash Flow From Operations | (124.2 M) | ||||
| Short Ratio | 5.29 X | ||||
| Earnings Per Share | (1.46) X | ||||
| Target Price | 91.97 | ||||
| Number Of Employees | 610 | ||||
| Beta | 1.01 | ||||
| Market Capitalization | 7.72 B | ||||
| Total Asset | 728.29 M | ||||
| Retained Earnings | (1.62 B) | ||||
| Working Capital | 544.25 M | ||||
| Current Asset | 541.82 M | ||||
| Current Liabilities | 140.69 M | ||||
| Net Asset | 728.29 M |
About Intracellular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intracellular Th's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intracellular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intracellular Th based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Intracellular Piotroski F Score and Intracellular Altman Z Score analysis. Note that the Intracellular Th information on this page should be used as a complementary analysis to other Intracellular's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Intracellular Stock analysis
When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Intracellular's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Revenue Per Share 4.843 | Quarterly Revenue Growth 0.503 | Return On Assets (0.13) | Return On Equity (0.22) |
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.